| Jennifer Y Hsu, MD | |
|
13580 Groupe Dr Ste 105, Woodbridge, VA 22192-4163 | |
| (703) 680-1770 | |
| (855) 402-1839 |
| Full Name | Jennifer Y Hsu |
|---|---|
| Gender | Female |
| Speciality | Obstetrics & Gynecology - Reproductive Endocrinology |
| Location | 13580 Groupe Dr Ste 105, Woodbridge, Virginia |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1063755163 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207VE0102X | Obstetrics & Gynecology - Reproductive Endocrinology | 0101269290 (Virginia) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Jennifer Y Hsu, MD 9600 Blackwell Rd Ste 500, Rockville, MD 20850-3783 Ph: () - | Jennifer Y Hsu, MD 13580 Groupe Dr Ste 105, Woodbridge, VA 22192-4163 Ph: (703) 680-1770 |
News Archive
Taking medications as prescribed is challenging for many patients, and following doctors' orders regarding medication often varies over time and among different patients. The consequences of failing to follow the prescribed medication regimen range from mild to life-threatening, depending on the medication and the illness or condition being treated.
Scientists are reporting discovery of a potential new drug for epidemic keratoconjunctivitis (EKC) - sometimes called "pink eye" - a highly infectious eye disease that may occur in 15 million to 20 million people annually in the United States alone. Their report describing an innovative new "molecular wipe" that sweeps up viruses responsible for EKC appears in ACS's Journal of Medicinal Chemistry.
Biomedical researchers at the University of Arkansas in Fayetteville and the University of Arkansas for Medical Sciences (UAMS) in Little Rock have developed a special contrast-imaging agent made of gold-coated carbon nanotubes that is capable of molecular mapping of lymphatic endothelial cells and detecting cancer metastasis in sentinel lymph nodes.
Today, the U.S. Food and Drug Administration granted accelerated approval to Jemperli (dostarlimab) for treating patients with recurrent or advanced endometrial cancer that has progressed on or following prior treatment with a platinum-containing chemotherapy and whose cancers have a specific genetic feature known as dMMR (which contain abnormalities that affect the proper repair of DNA inside the cell), as determined by an FDA-approved test.
› Verified 2 days ago
Dr. Grigor Khachikian, MD Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 1950 Opitz Blvd, Woodbridge, VA 22191 Phone: 703-551-4656 Fax: 703-497-4167 | |
Dr. Brad B Swelstad, MD Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 13580 Groupe Dr Ste 105, Woodbridge, VA 22192 Phone: 703-680-1770 Fax: 855-402-1839 | |
Dr. John D Long Jr., MD Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 14139 Potomac Mills Rd, Kaiser Permanente Woodbridge Medical Center, Woodbridge, VA 22192 Phone: 703-490-8400 Fax: 703-490-7635 | |
Dr. Zohreh Nikkhah Abyaneh, MD Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 2026 Opitz Blvd Ste A, Woodbridge, VA 22191 Phone: 571-992-8005 Fax: 703-494-3958 | |
Michael Q Smith, MD Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 4379 Ridgewood Center Dr Ste 102, Woodbridge, VA 22192 Phone: 703-680-7950 Fax: 703-680-7953 | |
Dr. Beverly Waddell-jiggetts, MD Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 14139 Potomac Mills Road, Woodbridge, VA 22192 Phone: 703-490-8400 Fax: 703-490-7701 |